SUBSCRIBE

Breaking News on Supplements & Nutrition - EuropeUS edition

Report abuse about a comment

Resveratrol 2012

I, along with about 80 of the most important scientists and physicians in the US, Europe, Middle East, and Asia just participated in the Resveratrol 2012 scientific conference in the UK. The evidence for resveratrol's ability to prevent, and treat the diseases of our modern lifestyle and obesity were impressive to say the least. When I was interviewed 6 years ago I stated that Transmax resveratrol would be ultimately considered more important to human health than penicillin. At the conference, after my presentation, I amended this statement. I now believe that Transmax resveratrol will be more important to all antibiotics within 20 years. Its potential to prevent diabetes, cancers, cardio-vascular disease, and inflammatory conditions is unique amongst both natural compounds and pharmaceuticals.

Posted by James Betz
23 December 2012 | 21h21

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: DMAA, resveratrol, gut health, and omega-3’s: A year of science in the nutra sector

Spotlight

EFSA claim for pro- and prebiotics getting closer, but industry is wary of rushing
"I think everybody would love to see at least one approved health claim in these areas at some point in time”

EFSA claim for pro- and prebiotics getting closer, but industry is wary of rushing

There is a general feeling that probiotic and prebiotic producers are getting closer to receiving their categories'...

Sweden finds unlisted pharmas in sex shop food supplements

Swedish agency comes down hard on unlisted pharmas in libido-boosting supplements

The Swedish Medical Products Agency (MPA) says nearly 70% of ‘sexual potency’ food supplements it tested contained...

EFSA panel member spells out lessons for health claim applications
Dispatches from Hi Europe

EFSA panel member spells out lessons for health claim applications

Good science and trial design must be a focus for companies putting together new health claims dossiers,...

Naturally opposed? Balancing new technologies with consumer perceptions
Comment

Naturally opposed? Balancing new technologies with consumer perceptions

New technologies are vital to the future growth of the food and nutrition industry, but their future...

NutraIngredients' top stories of 2014

NutraIngredients' top stories of 2014

Omega-3 breakthroughs, political shake-ups and health claim fines. 

Key Industry Events

 

Access all events listing

Our events, Events from partners...